Clinical Trial Update: A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating withdrawal strategies for steroids or tacrolimus in kidney transplant recipients; completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Kidney Failure

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Failure, Graft vs Host Disease | Phase 4 | Status: COMPLETED | Results posted: 2009-06-02